NovaBay Pharmaceuticals, Inc. (NBY) is around the top of the Biotechnology industry according to InvestorsObserver. NBY received an overall rating of 51, which means that it scores higher than 51 percent of all stocks. NovaBay Pharmaceuticals, Inc. also achieved a score of 77 in the Biotechnology industry, putting it above 77 percent of Biotechnology stocks. Biotechnology is ranked 89 out of the 148 industries.
NBY has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on NBY!